Home » Topics » Science » New compound

New compound
RSS

Parke-Davis develops new c-src TK inhibitors

May 12, 1997

RPR selects farnesyltransferase inhibitor for in vivo evaluation

May 12, 1997

Schering-Plough evaluates novel farnesyltransferase inhibitor

May 12, 1997

New class of topo I inhibitors designed for oral administration

May 9, 1997

Natural cancer immunotherapeutic discovered by Yonsei University researchers

May 9, 1997

Novel EGF receptor TK inhibitor described by Mitsubishi

May 9, 1997

BM-92.0700: a promising anticancer clinical candidate

May 9, 1997

Kowa/Vrije University researchers identify potent CysLT1 receptor antagonists

May 7, 1997

New ganciclovir derivative from Norsk Hydro for HSV infections

May 5, 1997

Agouron presents rhinovirus 3C protease inhibitor as promising clinical candidate

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...